{
    "eid": "2-s2.0-85168588800",
    "title": "Immune Checkpoint Inhibitor-Associated Striatal Encephalitis Presenting with Subacute Progressive Parkinsonism",
    "cover-date": "2023-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neurology",
            "@code": "2808",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Neurology (clinical)",
            "@code": "2728",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Atezolizumab",
        "immune checkpoint inhibitor",
        "neurotoxicity",
        "parkinsonism",
        "striatal encephalitis"
    ],
    "authors": [
        "Tittaya Prasertpan",
        "Nattaya Teeyapun",
        "Roongroj Bhidayasiri",
        "Jirada Sringean"
    ],
    "citedby-count": 1,
    "ref-count": 15,
    "ref-list": [
        "Neurotoxicities associated with immune checkpoint inhibitor therapy",
        "Atezolizumab-induced encephalitis in a patient with hepatocellular carcinoma: a case report and literature review",
        "Encephalitis induced by immune checkpoint inhibitors: a systematic review",
        "Neuroimmunological adverse events associated with immune checkpoint inhibitor: a retrospective, pharmacovigilance study using FAERS database",
        "Atezolizumab-induced encephalitis in metastatic bladder cancer: a case report and review of the literature",
        "Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis",
        "Case report: immune-mediated cerebellar ataxia secondary to anti-PD-L1 treatment for lung cancer",
        "Acute cerebellar ataxia induced by nivolumab",
        "Nivolumab-induced autoimmune encephalitis in two patients with lung adenocarcinoma",
        "Central nervous system complications associated with immune checkpoint inhibitors",
        "Bilateral thalamic lesions associated with Atezolizumab-induced autoimmune encephalitis",
        "Neurological complications of cancer immunotherapy",
        "Atezolizumab-related encephalitis in the intensive care unit: case report and review of the literature",
        "Atezolizumab-induced encephalitis in metastatic lung cancer: a case report and literature review",
        "Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "106208652",
            "affilname": "Academy of Science",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/106208652",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}